Department of Neurosurgery, Medical Trust Hospital, M.G. Road, Kochi, Kerala, 682020, India.
Acta Neurochir (Wien). 2018 Jun;160(6):1291-1299. doi: 10.1007/s00701-018-3538-4. Epub 2018 Apr 26.
Use of ICP monitoring is considered to be part of "standard of care" in management of severe traumatic brain injury, but it is rarely used in developing countries. The authors present a study which evaluates the efficacy and outcomes of ICP monitoring at a high-volume trauma center in India.
Data on management and outcomes for 126 patients who were admitted with diffuse traumatic brain injury (GCS 3-8) were studied prospectively over an 18-month period. These patients were treated by one of the two specific protocols: ICP monitoring-based or non-ICP monitoring-based. The primary outcome was measured based on 2 weeks mortality and GOS-E at 1, 3, and 6 months. Secondary outcome was measured based on need for brain-specific treatment, length of ICU stay, and radiation exposure.
Mortality in a subset of patients who underwent surgical intervention later due to increased ICP values, drop in GCS, or radiological deterioration was noted to be significantly lower in the ICP monitoring group (p = 0.03), in spite of statistically insignificant difference in overall mortality rates between groups. GOS-E scores at 1 month were significantly better (p = 0.033) in ICP monitoring group, even though they equalized at 3 and 6 months. The need for brain-specific treatment (p < 0.001), radiation exposure (p < 0.001), and length of ICU stay (p = 0.013) was significantly lower in the ICP monitoring group.
ICP monitoring-based treatment protocol helps in achieving faster recovery; lowers mortality rates in operated patients; and reduces ICU stay, radiation exposure, and the need for brain-specific treatment.
在严重创伤性脑损伤的管理中,使用颅内压监测被认为是“标准护理”的一部分,但在发展中国家很少使用。作者介绍了一项在印度一家大容量创伤中心评估颅内压监测的疗效和结果的研究。
对 126 例弥漫性创伤性脑损伤(GCS 3-8)患者的管理和结果进行前瞻性研究,时间为 18 个月。这些患者采用两种特定方案之一进行治疗:基于颅内压监测的或非基于颅内压监测的。主要结局指标是根据 2 周死亡率和 1、3、6 个月的 GOS-E 来测量。次要结局指标是根据需要进行脑特异性治疗、ICU 住院时间和辐射暴露来测量。
在因颅内压升高、GCS 下降或影像学恶化而随后接受手术干预的患者亚组中,颅内压监测组的死亡率显著降低(p=0.03),尽管两组之间的总死亡率存在统计学上的显著差异。颅内压监测组的 1 个月 GOS-E 评分显著更好(p=0.033),尽管在 3 和 6 个月时相等。颅内压监测组需要进行脑特异性治疗(p<0.001)、辐射暴露(p<0.001)和 ICU 住院时间(p=0.013)显著降低。
基于颅内压监测的治疗方案有助于更快地恢复;降低手术患者的死亡率;并减少 ICU 住院时间、辐射暴露和脑特异性治疗的需求。